Adverse events following immunization of COVID-19 vaccine among children aged 6–11 years

INTRODUCTION: Starting in December 2021, the Indonesian Government has recommended inactivated SARS-CoV-2 vaccine (CoronaVac) for children aged 6–11 years. This study aims to determine the prevalence and determinant factors of adverse events following immunization (AEFI) of the first dose and the se...

Descripción completa

Detalles Bibliográficos
Autores principales: Puspitarani, Fitriana, Sitaresmi, Mei Neni, Ahmad, Riris Andono
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640945/
https://www.ncbi.nlm.nih.gov/pubmed/36388348
http://dx.doi.org/10.3389/fpubh.2022.999354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640945/
https://www.ncbi.nlm.nih.gov/pubmed/36388348
http://dx.doi.org/10.3389/fpubh.2022.999354

Ejemplares similares